Pharmacology News

The timing of when a patient takes their blood pressure medication does not appear to matter for reducing CV event risk, according to two trials and a meta-analysis presented at the European Society of Cardiology Congress.

Placebos administered without deception, or nondeceptive placebos, may offer an alternative and effective way to help people manage prolonged stress, according to a study published in Applied Psychology: Health and Well-Being.

High BMI eligibility for semaglutide could cost Medicare up to $145 billion annually, a brief report published in the Annals of Internal Medicine revealed.

The FDA on Thursday announced that it has greenlit the updated COVID-19 vaccines manufactured by Moderna and Pfizer-BioNTech, which the companies said should be available within days.

The Infectious Diseases Society of America has updated its guidance on the treatment of antimicrobial-resistant gram-negative infections and said it aims to update the guidelines annually to keep up with evolving resistance and new research.

A 90-day supply of most of the top generic drugs in the U.S. can be purchased from a discount program for $15 or less, but none of the programs consistently offer the lowest prices for generic drugs, according to two presenters.

In this podcast episode, Tom McCourt, chief executive officer of Ironwood Pharmaceuticals, discusses the evolving relationship between physicians and pharma, breakthroughs in GI drugs and more.

More than half of antibiotic prescriptions for acute sinusitis follow prescribing guidelines, but nearly one-third do not, and most prescriptions are given for too long a duration, according to a study.

The Centers for Medicare & Medicaid Services announced lower Medicare Part D prices for 10 drugs that will take effect in 2026, according to a press release.